Tags

Type your tag names separated by a space and hit enter

The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer.
Breast Cancer Res Treat. 2009 Dec; 118(3):661-3.BC

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Letter

Language

eng

PubMed ID

19714461

Citation

Yu, Ke-Da, et al. "The Immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" Subgroup Is Not a Surrogate for the Normal-like Subtype in Breast Cancer." Breast Cancer Research and Treatment, vol. 118, no. 3, 2009, pp. 661-3.
Yu KD, Shen ZZ, Shao ZM. The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer. Breast Cancer Res Treat. 2009;118(3):661-3.
Yu, K. D., Shen, Z. Z., & Shao, Z. M. (2009). The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer. Breast Cancer Research and Treatment, 118(3), 661-3. https://doi.org/10.1007/s10549-009-0522-y
Yu KD, Shen ZZ, Shao ZM. The Immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" Subgroup Is Not a Surrogate for the Normal-like Subtype in Breast Cancer. Breast Cancer Res Treat. 2009;118(3):661-3. PubMed PMID: 19714461.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer. AU - Yu,Ke-Da, AU - Shen,Zhen-Zhou, AU - Shao,Zhi-Ming, PY - 2009/08/17/received PY - 2009/08/19/accepted PY - 2009/8/29/entrez PY - 2009/8/29/pubmed PY - 2010/1/23/medline SP - 661 EP - 3 JF - Breast cancer research and treatment JO - Breast Cancer Res Treat VL - 118 IS - 3 SN - 1573-7217 UR - https://www.unboundmedicine.com/medline/citation/19714461/The_immunohistochemically_"ER_negative_PR_negative_HER2_negative_CK5/6_negative_and_HER1_negative"_subgroup_is_not_a_surrogate_for_the_normal_like_subtype_in_breast_cancer_ L2 - https://doi.org/10.1007/s10549-009-0522-y DB - PRIME DP - Unbound Medicine ER -